Overexpression of xCT correlates with tumor invasion, short survival, and a poor prognosis in patients and animal models of hepatocarcinoma (77, 216), acute myeloid leukemia (217), non-small cell lung cancer (68), prostate cancer (218), and colorectal cancer (219). Here, SLC7A11 is linked to colorectal cancer.